Showing results (91-100 of 201) with videos related to
Sort By:
Pageof 21
Frontiers in Immunology|March 7, 2022
Chemokine-Driven Migration of Pro-Inflammatory CD4+ T Cells in CNS Autoimmune DiseaseAaron H S Heng, Caleb W Han, Caitlin Abbott, et al.The Journal of Biological Chemistry|May 31, 1996
Physical association of Gi2alpha with interleukin-8 receptorsB B Damaj, S R McColl, W Mahana, et al.Journal of Biomedical Materials Research|August 22, 2000
Protein adsorption and platelet attachment and activation, on TiN, TiC, and DLC coatings on titanium for cardiovascular applicationsM I Jones, I R McColl, D M Grant, et al.Life (Basel, Switzerland)|October 23, 2021
CXCR4-CCR7 Heterodimerization Is a Driver of Breast Cancer ProgressionValentina Poltavets, Jessica W Faulkner, Deepak Dhatrak, et al.Rural and Remote Health|September 11, 2010
A multi-university study of which factors medical students consider when deciding to attend a rural clinical school in AustraliaLee M Krahe, Alexander R McColl, Julie F Pallant, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|September 28, 2004
Control of Salmonella dissemination in vivo by macrophage inflammatory protein (MIP)-3alpha/CCL20Olivier L Fahy, Scott L Townley, Nicholas J Coates, et al.The Journal of Biological Chemistry|May 19, 2000
Stimulation of human neutrophils by chemotactic factors is associated with the activation of phosphatidylinositol 3-kinase gammaP H Naccache, S Levasseur, G Lachance, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1989
Chemoattractant-induced cytoplasmic pH changes and cytoskeletal reorganization in human neutrophils. Relationship to the stimulated calcium transients and oxidative burstP H Naccache, S Therrien, A C Caon, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous systemRachel E Kohler, Adriana C Caon, David O Willenborg, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 2, 1998
Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitisS R McColl, M A Staykova, A Wozniak, et al.Pageof 21